Ankylosing spondylitis is a type of arthritis that primarily affects the spine and causes the vertebrae and surrounding tissue to fuse. The unnatural fusing results in inflammation and causes sharp bouts of pain. This happens due to the formation of new bones in the existing vertebrae sections. In severe cases, spondylitis can cause the spine to hu
Read MoreThe Philips B-Line BFL2114 58" class 4K UHD smart professional LED television offers the best viewing experience when you need to easily share content across multiple devices in your huddle space. Even if you have never used a Philips TV before, there...
Faster shipping. Better service
2811 Wilshire Boulevard Suite 810,Santa Monica,CA
About Dr. Mark J. Kelly Dr. Mark J. Kelly, MD, is widely considered as one of the pillars of strength in the Urology field in Los Angeles over the last 25 years. He is often called the Doctors Urologist. He is certified by the American Board of Urology, the longstanding Chief of Urology at Saint Johns Health Center, and an Assistant Professor of Urological Oncology at the John Wayne Cancer Institute in Santa Monica, California. Dr. Kellys operates a state-of-the-art private practice in Santa Monica where he offers truly personalized and cutting-edge care for his patients. Dr. Kelly is a leading pioneer in the management of prostate cancer with expertise in prostate cancer detection, risk assessment, and in the performance of highly precise MRI Image-Guided Fusion Biopsy which can precisely locate prostate cancer. In many cases, this precision can result in the ability to recommend either no immediate treatment or, if necessary, Focal Treatment for ones prostate cancer. Focal Therapy has the potential to cure those prostate cancers that should be treated while minimizing the well-established side effects of invasive robotic surgery and radiation therapy including urinary incontinence, erectile dysfunction, and rectal injury. Dr. Kelly is one of the only doctors in Greater Los Angeles to offer the ICEfx™ cryoablation system, which allows him to treat tumors without surgery and without causing sexual or urinary side effects. In addition to diagnosing and treating prostate cancer, Dr. Kelly has expertise in a full range of mens health issues, including all diseases of the male reproductive and urinary system. He has extensive experience in treating erectile dysfunction, including prosthetic surgery, helping men manage andropause and low testosterone, and diagnosing and treating sexually transmitted diseases. Dr. Kelly attended the prestigious Albert Einstein College of Medicine in New York City. After graduating, Dr. Kelly moved to Los Angeles, where he completed residencies in general surgery and urology at Kaiser Foundation Hospital under the tutelage of the world-renowned Dr. Stanley Brosman, who supervised Dr. Kellys urology residency and subsequently invited him to begin his private practice at Saint Johns. While at Saint Johns, Dr. Kelly worked with Dr. Donald Morton, the founding surgeon of the widely respected John Wayne Cancer Institute, a component of Saint Johns Health Center. To schedule an appointment with Dr. Kelly, call the Medical Office of Mark J. Kelly, MD, Inc. or request a consultation online. Click here to read Dr. Kelly's CV!
(131) 082 - 9003
2121 Santa Monica Blvd Garden Level,Santa Monica,CA
Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.
(131) 058 - 2710
1245 Wilshire Blvd Suite 303,Los Angeles,CA
Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.
(180) 020 - 3551
240 South Jackson Street Suite 109,Glendale,CA
Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.
(180) 020 - 3551
2151 N Harbor Blvd Suite 1500,Fullerton,CA
The Fred A. Jordan Family Radiation Oncology Center combines the latest technological advances with the expertise of board-certified radiation oncologists considered among the best in their field. The result is were able to fight cancer more precisely and successfully than ever before, offering our patients better outcomes and fewer side effects.
(171) 444 - 6563
Copyright 2024. All Rights Reserved.